Ms Mahony joined Lilly more than eight years ago, after more than a decade in sales and marketing roles in the UK and Europe for Amgen, Bristol-Myers Squibb and Schering-Plough. She was named general manager of Lilly Canada in 2008 after roles in global marketing and new product development, including a leadership role in the development of Cymbalta.
John Lechleiter, Lilly’s chairman, president and CEO, said: “Sue brings a fresh perspective that will help guide the way we anticipate and respond to a rapidly changing environment. Her prior experiences, coupled with her record of strong leadership, will enable Lilly to sustain a strong human resources function and ensure that we are able to compete and win in the face of unprecedented challenge and opportunity.”